11␤-Hydroxysteroid dehydrogenase (11␤HSD) is an enzyme complex responsible for the conversion of hormonally active cortisol to inactive cortisone; two isoforms of the enzyme have been cloned and characterized. Clinical observations from patients with the hypertensive syndrome apparent mineralocorticoid excess, recently explained on the basis of mutations in the human 11␤HSD2 gene, suggest that it is the 11␤HSD2 isoform that serves a vital role in dictating specificity upon the mineralocorticoid receptor (MR). We have raised a novel antibody in sheep against human 11␤HSD2 using synthetic multiantigenic peptides and have examined the localization and subcellular distribution of 11␤HSD2 in mineralocorticoid target tissues.
T HE ENZYME COMPLEX 11␤-HYDROXYSTEROID dehydrogenase (11␤HSD) is responsible for the interconversion of cortisol to hormonally inactive cortisone. Two isoforms of 11␤HSD have been cloned and characterized in human tissues (1-3), but it is the 11␤HSD2 isozyme that dictates specificity upon the mineralocorticoid receptor (MR). In vitro the MR has equal affinity for aldosterone and cortisol (4) , but the inactivation of cortisol to cortisone in the kidney, colon, and salivary gland ensures that normal in vivo specificity for the MR is maintained with the binding of aldosterone (5, 6) . Apparent mineralocorticoid excess is a form of human hypertension due to mutation in the gene encoding 11␤HSD2 (7-9); a defect in this cortisol-cortisone shuttle mechanism results, and cortisol acts as a potent mineralocorticoid (10, 11) . Inhibition of 11␤HSD2 also explains the mineralocorticoid excess state seen after licorice ingestion (12) , and the enzyme is overwhelmed by substrate excess in the ectopic ACTH syndrome (13, 14) . Thus, 11␤HSD2 serves an important role in normal physiology, and alterations in its activity are involved in the pathogenesis of human hypertension.
11␤HSD2 messenger RNA and activity have been demonstrated in human kidney and colon (3, 15) . In the colon, activity studies have suggested that 11␤HSD2 is expressed in the surface epithelial cells (16) , the site of expression of the MR. Furthermore, in situ hybridization (15) and immunohistochemistry studies (17, 18) have confirmed the site of expression of 11␤HSD2 within the kidney to be the MRexpressing collecting ducts. However, there remains some debate as to whether other structures within the kidney express 11␤HSD2, such as the vasculature. In addition, although 11␤HSD2 has been considered to be a microsomal enzyme, earlier activity studies in kidney tissue did suggest the presence of 11␤HSD activity within a crude nuclear fraction (19, 20) .
Using a sheep antiserum raised against human 11␤HSD2, we carried out immunohistochemical studies, including confocal microscopy and Western blot analyses, to characterize and more clearly define the localization of 11␤HSD2 within human mineralocorticoid target tissues.
Materials and Methods
Tissues were obtained from the Department of Pathology, University of Birmingham. In every case tissues were histologically normal, derived from kidney, colon, and parotid gland. In each case a minimum of four separate normal tissues were studied, and the results shown to be consistent. Formalin-fixed, paraffin-wax embedded sections (5 m) were mounted onto charged glass slides.
Synthesis of a human 11␤HSD2 antiserum
Using hydrophilicity profiles, two regions were selected from the published amino acid sequence of the type 2 isoform of human 11␤HSD, amino acids 137-160 and 334 -358. These sequences were synthesized as eight-branched multiantigenic peptides and the two multiantigenic peptides mixed with Freund's complete adjuvant and used to immunize a single sheep. An IgG fraction was prepared from the immune serum by ammonium sulfate precipitation and ion exchange chromatography.
Immunoperoxidase method
Sections were dewaxed in xylene, washed, and then boiled in 0.01 m citrate buffer, pH 6.0, for 2 min. After cooling at room temperature, endogenous peroxidase was blocked with 0.3% hydrogen peroxide in methanol for 15 min. The sections were rinsed in 0.05 m Tris-buffered saline, pH 7.6 (TBS), and incubated with human 11␤HSD2 antiserum [1:100 dilution in 10% normal swine serum in TBS (NSS/TBS)] for 60 min at room temperature. After washing in TBS, a 1:25 dilution of an antidonkey sheep horseradish peroxidase conjugate (Binding Site, Birmingham, UK) was applied to the sections for 30 min. Sections were rinsed in TBS covered with 10 mg 3,3Ј-diaminobenzidine tetrahydrochloride in 20 ml 0.1 m Tris buffer, pH 8.2, with 20 l hydrogen peroxide for 10 min. The sections were washed in tap water, counterstained with hematoxylin, dehydrated, and mounted.
Immunofluorescence and confocal laser microscopy
This was carried out on human kidney tissues. Paraffin sections were processed as described above, incubated with a 1:25 dilution of the 11␤HSD2 antiserum in 10% NSS/TBS for 60 min, washed in PBS for 10 min, and then incubated with a 1:25 dilution of an antidonkey sheep fluorescent conjugate (Binding Site) for 30 min. Sections were washed in PBS for 60 min and then counterstained with the nuclearspecific propidium iodide (0.5 g/ml) (21) and rinsed in PBS. Sections were mounted in glycerol containing 1,4-diazabicyclo-(2.2.2) octane and initially examined under a Zeiss Universal fluorescent microscope as previously reported (22) . A Bio-Rad 500 laser scanning confocal system (Bio-Rad, Richmond, CA) attached to a Leitz SM-Lux microscope (Leitz, Rockleigh, NJ) was used to analyze the sections through an optical section of approximately 0.1 m (in contrast to the immunoperoxidase studies analyzed on the light microscope on 5-m sections) (23) . The determination of nuclear vs. cytoplasmic 11␤HSD2 immunofluorescence within human kidney and colon was achieved by simultaneous multichannel analysis on the dual labeled sections (11␤HSD2 and propidium iodide) by merging and displacing the paired images collected in the dual fluorescence mode, again through an optical section of 0.1 m. From a mean of 10 epithelial cells in any given field, quantification of the 2 fluorescent labels was measured, from which the relative nuclear area and nuclear fluorescent signal could be calculated. Finally, by optical scanning of the section in the z or vertical axis, determination of whether nuclear staining was membrane or internal was made.
Controls
In each case negative controls were carried out with the primary antiserum omitted, but in the presence of 10% NSS. Further extensive control experiments were carried out using the immunizing 11␤HSD2 peptides. Peptide 1 (representing amino acids 137-160 of 11␤HSD2; 11.0 mg/ml) and peptide 2 (amino acids 334 -358; 4.1 mg/ml) were diluted with 10% NSS/TBS from 1:2 to 1:128,000 dilution and incubated with the 11␤HSD2 antiserum (1:100 dilution with the diluted peptide) at 4 C overnight. After centrifugation, the supernatants were taken and used as the primary antiserum as described above.
Western blot analysis
Western analysis of proteins, prepared from homogenates of intact term placenta, trophoblast, and decidua; adrenal; liver; colon; and kidney, was performed by SDS-PAGE on discontinuous acrylamide gels. After a series of preliminary experiments to optimize conditions, 15 g sample protein were denatured at 95 C in 2% SDS, 10% glycerol, 62.5 mm Tris (pH 6.8), and 0.1% dithiothreitol and electrophoresed at 200 mV through 4.5% stacking and 10% resolving gels using a MiniProtean II Western apparatus (Bio-Rad). After electrophoresis, proteins were transferred to Immobilon P membranes (Millipore Corp., Bedford, MA), the membranes were blocked with 20% nonfat milk in PBS-0.1% Tween-20 (PBS-T) for 1 h, washed three times in PBS-T, and incubated with a 1:1000 dilution of the human 11␤HSD2 antiserum in 0.05% PBS-T overnight at 4 C. After washing in 0.1% PBS-T, membranes were incubated with a 1:50,000 dilution of an antisheep IgG peroxidase conjugate for 90 min at room temperature. Protein bands were analyzed using the ECL detection system (Amersham International, Aylesbury, UK) and exposed immediately to DuPont Cronex x-ray film (Wilmington, DE) for 10 min. Western blot analysis was also carried out on kidney and colon using antisera preincubated with a 1:64,000 dilution of peptide 1 mixed with a 1:16 dilution of peptide 2 (see below).
Results

Localization of 11␤HSD2 within mineralocorticoid target tissues
Kidney. Intense immunoreactivity was seen only in cortical and medullary collecting ducts. No staining was observed over vascular structures, glomeruli, proximal tubules, thin limbs of the loop of Henle, or thick limbs of the loop of Henle, identified by their positions in the outer medulla, in medullary rays in the cortex, and at the macula densa adjacent to glomeruli. In the collecting ducts, immunoreactivity for 11␤HSD2 was much stronger in some cells than others; these have the morphological characteristics of principal cells, although specific markers for these cells were not employed (Fig. 1a) .
Colon. Immunoreactivity was seen in the epithelium of the colon, with the greatest intensity in the surface epithelium. Staining was also seen in the crypt epithelial cells, but immunoreactivity was absent elsewhere in the colon (Fig. 1c) .
Salivary gland. Immunoreactivity was seen in the epithelium of ducts in the parotid gland, with no detectable staining of glandular acini, adipocytes, or connective tissues (Fig. 1d) .
The specificity of the antisera was confirmed by demonstrating the absence of staining with omission of the antiserum in the presence of normal sheep serum and also from the control studies with the immunizing peptide. Thus, with peptide 1, dilutions of 1:2 to 1:64,000 added to the antisera showed no staining, whereas a 1:128,000 showed some positivity over renal collecting ducts. With peptide 2, the absence of staining was seen with dilutions of 1:2 to 1:16, but positivity was restored when dilutions of 1:32 and less were used. The negative controls depicted here used a 1:64,000 dilution of peptide 1 mixed with a 1:16 dilution of peptide 2 incubated with the antisera as described in Materials and Methods (Fig.  1b) . Further negative controls were carried out on human liver tissue that was devoid of any immunoreactivity (data not shown). The antibody was further characterized by Western blot analysis.
Western blot analysis of 11␤HSD2 in human mineralocorticoid target tissues
A single band of approximately 44 kDa was observed in term placenta and trophoblast and colon, but not in de-cidua, adrenal, or liver. In renal tissue, a second band was seen of approximately 48 kDa (Fig. 2a) . The significance of this is uncertain, but has been a consistent finding in our Western blot analysis of human renal tissue (both cortex and medulla). Both the 44-and 48-kDa bands were eliminated in the presence of the absorbed antiserum (Fig. 2b) . No additional bands were found in placenta or colon.
Confocal laser microscopy
From the immunoperoxidase studies, carried out on 5-m sections of kidney, colon, and salivary gland; counterstained with hematoxylin; and analyzed under the light microscope, it was not possible to comment upon the subcellular localization of 11␤HSD2. This was achieved, however, using confocal laser microscope, which analyzes the section through an optical plane of approximately 0.1 m (23). 11␤HSD2 immunofluoresence in epithelial cells of renal collecting ducts and colonic mucosal was seen, in keeping with the immunoperoxidase results. For kidney sections, when the paired images from the 11␤HSD2 (green) and propidium iodide (red) fluorescent signals were merged, it was clear that a proportion of the 11␤HSD2 fluorescence was over the nuclear area (yellow; Fig. 3a) . Similar findings were found in colonic epithelial cells (Fig. 3b) . The apparent differences in the degree of yellow staining in Fig. 3, a and b , reflect the relative sizes of the nucleus in kidney and colonic epithelial cells. Thus, for the kidney section, the nuclear area was 63 Ϯ 4% (mean Ϯ sd; n ϭ 10) of the total cell area, whereas in the colon, the corresponding value was 39 Ϯ 3%. Nevertheless, by calculating cellular 11␤HSD2 immunofluorescence before and after subtraction of the nuclear area (as reflected by the propidium iodide fluorescence), the nuclear distribution of 11␤HSD2 was remarkably constant in both tissues (39 Ϯ 6% of the total cellular 11␤HSD2 immunofluorescence in kidney and 38 Ϯ 9% in colon). Analysis of sections in the vertical axis (z-series) indicated that this staining was not localized to the nuclear membrane itself, but was intranuclear in origin. This is clearly demonstrated in a higher magnification of renal collecting duct epithelial cells (Fig. 3c) .
Discussion
The recent past has seen significant advances in our understanding of 11␤HSD and MR hormone action. Thus, until the early 1990s, only one 11␤HSD enzyme had been cloned and characterized (now called 11␤HSD1) (1) . However, it soon became apparent that this enzyme could not confer specificity upon the MR. Kinetically, it was a low affinity dehydrogenase with a greater affinity for cortisone than cortisol (2) . In contrast to the epithelial localization of the MR to renal collecting ducts and colonic surface mucosal cells (24, 25) , rat 11␤HSD1 was found in renal proximal tubules (5) and nonepithelial cells within the colonic lamina propria (26) . Furthermore, in human kidney, very little, if any, 11␤HSD1 is expressed (1, 2) . In contrast, high affinity, NAD-dependent dehydrogenase activity was initially characterized in cultured rabbit collecting ducts (27) and subsequently in human placenta (28) and kidney (2) . The cloning of the enzyme simultaneously from human (3) and sheep kidney (29) has enabled the molecular basis for AME to be explained. This form of hypertension in which MR selectivity is lost, and cortisol acts as a potent mineralocorticoid arises because of mutations in the 11␤HSD2 gene (7-9).
In this study we have addressed the immunolocalization of 11␤HSD2 in human mineralocorticoid target tissues, kidney, colon, and salivary gland (24, 25, 30) using a novel antihuman 11␤HSD2 antiserum raised in sheep. The antibody recognizes a protein of approximately 44 kDa in human kidney, colon, and placenta, but not in human adrenal, liver, or decidua. This finding is in keeping with a predicted M r of 44.14 kDa for 11␤HSD2 and earlier reports on the expression of 11␤HSD2 messenger RNA in human tissues (3, 15) . 11␤HSD2 immunoreactivity was observed only in cells known to express the MR, i.e. cells within renal collecting ducts (24, 31) , surface and crypt epithelial cells within the colon (25) , and ductal epithelial cells within the parotid gland (30) , in keeping with the conclusion that 11␤HSD2 protects the MR in an autocrine fashion. Two recent reports, using differing 11␤HSD2 antisera, have described the immunolocalization of 11␤HSD2 within human kidney and colon (but not salivary gland) (17, 18) , and there are differences from our data. Krozowski et al. (17) report immunostaining to vascular endothelial cells within the kidney (although not apparently the placenta), a finding that we are unable to reproduce. Although vascular staining was not seen in the study by Kyossev et al. (18) , immunoreactivity was observed in the cortical ascending limb of the loop of Henle. We are confident that these tubular structures are negative in our study. The reasons for these discrepancies remain uncertain; whereas preimmune serum was used as a control in all three immunohistochemical studies, only our study used the more rigorous control of neutralizing the antiserum with the immunizing peptide.
The confocal laser microscopy presented here indicates that approximately 40% of the total immunostaining seen in renal collecting ducts and colonic epithelial cells is nuclear in origin. Furthermore, our data suggest that the enzyme is not associated with the nuclear membrane but has an intranuclear localization. 11␤HSD1 has been considered to be a microsomal enzyme (32) , with data also suggesting that it is found on the lumenal side of the endoplasmic reticulum (33) . There is, however, some evidence for nuclear 11␤HSD in kidney tissue. One of the first studies describing renal 11␤HSD activity indicated significant nuclear activity (19) , a finding that has been confirmed subsequently (20) , albeit on crude subcellular preparations and before the description of the two distinct isoforms of 11␤HSD. While this work was in progress, a fluorescent microscopy study reported that 11␤HSD2 is exclusively localized to the cytoplasmic surface of the endoplasmic reticulum (34) . This study, however, used a chimeric rabbit 11␤HSD2/green fluorescent protein fusion gene transfected into a nonmineralocorticoid target tissue, Chinese hamster ovary cells, and the significance of this work to our work on the human 11␤HSD2 in classical mineralocorticoid target tissues remains uncertain. Indeed, in view of the established role for 11␤HSD in protecting the MR, these data raise questions concerning the mechanisms underlying MR specificity and the intracellular trafficking of the MR. For other members of the steroid hormone receptor superfamily, such as the glucocorticoid and progesterone receptors, this is well char- acterized; after the binding of ligand to the receptor in the cytosol and the dissociation of heat shock proteins, the activated receptor complex is translocated to the nucleus (reviewed in Ref. 35 ). The intracellular localization of the MR, however, is still in some doubt. Although a predominantly cytosolic MR has been shown to translocate to the nucleus upon exposure to aldosterone in baculovirus-infected Sf9 cells (36) , data from rabbit (37) and rat kidney (24) and pituitary cells (38) suggest both a nuclear and a cytosolic localization for the MR, independent of ligand, suggesting that the interaction of the MR with its ligand may in part be a nuclear event. The data presented here on human kidney would be in keeping with these data; in a given mineralocorticoid-responsive epithelial cell, 11␤HSD2 is ideally placed both inside and outside the nucleus to confer specificity upon the MR. It remains to be seen whether this pattern of subcellular localization of the enzyme extends to other tissues expressing the MR and 11␤HSD2, for example in the central nervous system (39) , and if so, what factors in the structure of 11␤HSD determine this pattern of distribution. On this note, our Western blot analysis did reveal a second band of approximately 48 kDa in human kidney tissue homogenate, a band that was not observed in the study of Kyossev et al. (18) , who carried out Western analysis on microsomal fractions. It seems unlikely, however, that this second band reflects a modified nuclear 11␤HSD2 protein, because it was absent in the colon, where our confocal laser studies also confirmed nuclear localization of 11␤HSD2.
In summary, we have developed a novel human 11␤HSD2 antiserum and have used this to confirm that MR specificity is effected at an autocrine level within human kidney, colon, and parotid. The observation that a significant proportion of cellular 11␤HSD2 is localized to the nuclear compartment suggests that the interaction between the MR and its ligand, be it cortisol or aldosterone, is a nuclear event and as such is more akin to the thyroid hormone receptor than to its closer relatives in the steroid-thyroid hormone receptor superfamily, the glucocorticoid and progesterone receptors.
